1374 / 1674
Second Cancer by Time since Treatment
RT 23,627
Non-RT 22,549
OBS
Solid Second Cancers
HR (95% CI)
RT-associated sites
Non RT-associated sites
All sites
183,490
20,661
57,926
71,902
33,001
All
≥ 15
5-9
1-4
10-14
All
≥ 15
5-9
1-4
10-14
All
≥ 15
5-9
1-4
10-14
328
56
94
100
78
226
39
66
69
52
130,765
7,273
39,034
68,678
15,780
1,102
106
353
361
228
702
45
237
318
102
1,430
216
447
461
306
928
84
303
397
154
1.00 (0.86-1.16)
1.13 (0.97-1.32)
1.16 (0.95-1.42)
1.04 (0.79-1.37)
1.10 (1.01-1.21)
1.05 (0.89-1.25)
1.11 (0.93-1.32)
1.02 (0.81-1.31)
0.76 (0.53-1.09)
1.04 (0.94-1.16)
0.81 (0.58-1.14)
1.20 (0.86-1.69)
1.55 (1.08-2.24)
1.79 (1.14-2.81)
1.34 (1.11-1.61)
years latency
years latency
years latency
years latency
years latency
years latency
years latency
years latency
years latency
years latency
years latency
years latency
OBS Person years
Person years
0 .5 1 2
3 4
Grantzau et al. Radiotherapy and Oncology 2013; 106: 42-49